These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34715143)

  • 41. Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells.
    Borges KS; Castro-Gamero AM; Moreno DA; da Silva Silveira V; Brassesco MS; de Paula Queiroz RG; de Oliveira HF; Carlotti CG; Scrideli CA; Tone LG
    J Cancer Res Clin Oncol; 2012 Mar; 138(3):405-14. PubMed ID: 22160182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.
    Feng X; Zhang B; Wang J; Xu X; Lin N; Liu H
    Med Oncol; 2011 Mar; 28(1):24-30. PubMed ID: 20221717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment.
    Ceccherini E; Indovina P; Zamperini C; Dreassi E; Casini N; Cutaia O; Forte IM; Pentimalli F; Esposito L; Polito MS; Schenone S; Botta M; Giordano A
    J Cell Biochem; 2015 May; 116(5):856-63. PubMed ID: 25521525
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.
    Peterson TE; Kirkpatrick ND; Huang Y; Farrar CT; Marijt KA; Kloepper J; Datta M; Amoozgar Z; Seano G; Jung K; Kamoun WS; Vardam T; Snuderl M; Goveia J; Chatterjee S; Batista A; Muzikansky A; Leow CC; Xu L; Batchelor TT; Duda DG; Fukumura D; Jain RK
    Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4470-5. PubMed ID: 27044097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MGMT-inhibitor in combination with TGF-βRI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells.
    Das A; Henderson FC; Alshareef M; Porto GBF; Kanginakudru I; Infinger LK; Vandergrift WA; Lindhorst SM; Varma AK; Patel SJ; Cachia D
    Clin Transl Oncol; 2021 Mar; 23(3):612-619. PubMed ID: 32710211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gedunin modulates cellular growth and apoptosis in glioblastoma cell lines.
    Stouffer M; Wandling E; Dickson L; Lin S; Duan H; Powe E; Jean-Louis D; Tiwari AK; Amos S
    Cancer Rep (Hoboken); 2024 May; 7(5):e2051. PubMed ID: 38702989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion.
    Sorensen AG; Emblem KE; Polaskova P; Jennings D; Kim H; Ancukiewicz M; Wang M; Wen PY; Ivy P; Batchelor TT; Jain RK
    Cancer Res; 2012 Jan; 72(2):402-7. PubMed ID: 22127927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.
    Batchelor TT; Mulholland P; Neyns B; Nabors LB; Campone M; Wick A; Mason W; Mikkelsen T; Phuphanich S; Ashby LS; Degroot J; Gattamaneni R; Cher L; Rosenthal M; Payer F; Jürgensmeier JM; Jain RK; Sorensen AG; Xu J; Liu Q; van den Bent M
    J Clin Oncol; 2013 Sep; 31(26):3212-8. PubMed ID: 23940216
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a Brown Seaweed Extract from
    Dörschmann P; Schmitt C; Bittkau KS; Neupane S; Synowitz M; Roider J; Alban S; Held-Feindt J; Klettner A
    Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33302412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo.
    Li MY; Lv YC; Tong LJ; Peng T; Qu R; Zhang T; Sun YM; Chen Y; Wei LX; Geng MY; Duan WH; Xie H; Ding J
    Acta Pharmacol Sin; 2016 Mar; 37(3):398-407. PubMed ID: 26806300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.
    de Groot J; Liang J; Kong LY; Wei J; Piao Y; Fuller G; Qiao W; Heimberger AB
    Oncotarget; 2012 Sep; 3(9):1036-48. PubMed ID: 23013619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-200c-based metabolic modulation in glioblastoma cells as a strategy to overcome tumor chemoresistance.
    Cardoso AM; Morais CM; Sousa M; Rebelo O; Tão H; Barbosa M; Pedroso de Lima MC; Jurado AS
    Hum Mol Genet; 2021 Nov; 30(23):2315-2331. PubMed ID: 34245265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SB365 induces apoptosis and suppresses proliferation of glioblastoma cells.
    Lim JH; Jung KH; Kim MS; You JH; Park IS; Hong SS
    Indian J Pharmacol; 2020; 52(2):102-107. PubMed ID: 32565597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
    Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
    J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiR-144 overexpression as a promising therapeutic strategy to overcome glioblastoma cell invasiveness and resistance to chemotherapy.
    Cardoso AMS; Sousa M; Morais CM; Oancea-Castillo LR; Régnier-Vigouroux A; Rebelo O; Tão H; Barbosa M; Pedroso MCL; Jurado AS
    Hum Mol Genet; 2019 Aug; 28(16):2738-2751. PubMed ID: 31087038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced expression of pentraxin-3 in glioblastoma cells correlates with increased invasion and IL8-VEGF signaling axis.
    Wesley UV; Sutton I; Clark PA; Cunningham K; Larrain C; Kuo JS; Dempsey RJ
    Brain Res; 2022 Feb; 1776():147752. PubMed ID: 34906547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the Response of Intracranial Xenografts to VEGF Signaling Inhibition Using Multiparametric MRI.
    Boult JKR; Box G; Vinci M; Perryman L; Eccles SA; Jones C; Robinson SP
    Neoplasia; 2017 Sep; 19(9):684-694. PubMed ID: 28780387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Anti-angiogenic strategies in glioblastoma].
    Guillamo JS
    Rev Neurol (Paris); 2011 Oct; 167(10):662-7. PubMed ID: 21889779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting BC200/miR218-5p Signaling Axis for Overcoming Temozolomide Resistance and Suppressing Glioma Stemness.
    Su YK; Lin JW; Shih JW; Chuang HY; Fong IH; Yeh CT; Lin CM
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784466
    [No Abstract]   [Full Text] [Related]  

  • 60. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.
    Miekus K; Kijowski J; Sekuła M; Majka M
    Oncol Rep; 2012 Nov; 28(5):1903-9. PubMed ID: 22941268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.